CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $2.1M of Cerevel Therapeutics Holdings, Inc.
Sold$2,111,815
$42.24Price
50,000Shares
−95%Stake
What CERE did after the filing
- The stock from Fri, Jan 5 open, $42.19
- −2.7%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Feb 20 close.
Traded Tue, Jan 2. Filed Thu, Jan 4. Returns use the Jan 5 open and the Feb 20 close. Not investment advice.